Equity · Healthcare
CRMD
NASDAQCorMedix (CRMD)
The line runs 7.87 USD on 14 September through 5.49 USD on 9 November, on a scale from 5 to 9. Days the market did not trade hold the previous close, flat.
- Market cap
- 427.9M USD
- P/E (TTM)
- 2.5
- Revenue, year to Dec 2025
- 311.7M USD
- EPS, diluted, year to Dec 2025
- 2.04 USD
- 52-week range
- 5.22 USD – 12.75 USD
- Avg volume
- 117.8K
- Mentions, 30 days
- 2
as of Nov 9, 2026
Have CorMedix (CRMD) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no CorMedix insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest Form 4 filing 18 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Dillione JanetDirector | Option exercise | 48,909 | |
| 29 Aug 2026 | Blum SusanChief Financial Officer | Tax withheld | 8,424 | 70K USD |
| 29 Aug 2026 | Hurlburt ElizabethChief Operating Officer | Tax withheld | 8,076 | 67K USD |
| 29 Aug 2026 | Zelnick Kaufman BethChief Legal Officer | Tax withheld | 8,424 | 70K USD |
Which funds hold CorMedix (CRMD)?
6 of the 45 institutional funds we track reported a CorMedix position for the quarter ended 30 Jun 2026 — a combined 11.0M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Added | 779,535 | 6.1M USD | +55.0% |
| Balyasny Asset Management | New position | 202,370 | 1.6M USD | |
| D. E. Shaw & Co. | New position | 171,807 | 1.3M USD | |
| AQR Capital Management | Trimmed | 151,435 | 1.2M USD | −35.5% |
| Citadel Advisors | Trimmed | 56,614 | 444K USD | −76.7% |
| Two Sigma Investments | Added | 40,859 | 321K USD | +98.5% |
What has been filed or recorded for CorMedix (CRMD)?
The filings we hold for CorMedix, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Jun 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.29 USD | |
| 30 Jun 2026 | Financials | Total assets | 904.1M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 460.8M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.43 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 2.04 USD | Revenue $312M |
| 31 Dec 2025 | Financials | Revenue | 311.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 163.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 2.04 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 1.26 USD | Revenue $104M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.28 USD | Revenue $40M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.30 USD | Revenue $39M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.30 USD | Revenue $43M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.05 USD | Revenue $11M |
What is Reddit saying about CorMedix (CRMD)?
Reddit mentioned CRMD 2 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of CorMedix (CRMD) compare with its price?
Share ↗
Which subreddits are talking about CorMedix (CRMD)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 2 | +0.10 |
What do people ask about CorMedix (CRMD)?
What did CorMedix shares close at?5.49
CorMedix closed at 5.49 USD on 9 Nov 2026, up 3.58% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is CorMedix’s market cap?427.9M
CorMedix is worth 427.9M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is CorMedix’s P/E ratio?2.5
CorMedix has a price-to-earnings ratio of 2.5, as of 9 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is CorMedix’s revenue?311.7M
CorMedix reported revenue of 311.7M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have CorMedix insiders bought or sold shares recently?4 filings
In the 90 days to 10 Nov 2026, no CorMedix insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own CorMedix?6 of 45
6 of the 45 funds we track reported a CorMedix position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace, Balyasny Asset Management and D. E. Shaw & Co. See Funds
When did CorMedix last report earnings?0.29
CorMedix last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 0.29 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about CorMedix?0 mentions
CorMedix was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings